Orthopedic Biomaterials Market Size, Share & Trends Analysis Report By Product (Reconstructive Joint Replacement, Spinal Implants, Dental Implants, Trauma, Orthobiologics), By Material Class (Metal, Non-Metal), By Applications (Joint Replacement, Fracture Fixation, Tissue Fixation, Implant Surgery, Viscosupplementation), By End-User (Hospitals and Clinics, Ambulatory Surgical Center) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Orthopedic Biomaterials Market Size

The global orthopedic biomaterials market size was valued at USD 30.14 billion in 2025 and is projected to grow from USD 32.51 billion in 2026 to USD 59.50 billion by 2034, registering a CAGR of 7.85% during the forecast period from 2026 to 2034. Americas dominated the orthopedic biomaterials market with a market share of 39.2% in 2025.

Biomaterials are employed in numerous medical procedures, including orthopedics. Orthopedic biomaterials, which can be created from organic or synthetic materials, help bones that have been damaged by disease or trauma regain their structural integrity. Orthopedic biomaterials are used to construct medical devices that the human body can use to replace or repair tissues like ligaments, cartilage, bones, tendons, and more to carry out specific biological functions. The product has applications in orthobiologics, viscosupplementation, spine implants, joint replacement, and biodegradable tissue fixation.

Product Insights

The reconstructive joint replacement segment is the highest contributor to the market and is expected to grow at a CAGR of 7.88% during the forecast period. In 2022, the segment for reconstructive joint replacements held the largest share (31.96%). The rising number of orthopedic surgery cases and the aging population is responsible for this. Additionally, there has been a strong emphasis on enhancing healthcare services globally, accelerating the market's expansion. In addition, a medical procedure called reconstructive joint replacement involves replacing the injured joint. Joint reconstruction, which offers pain relief and long-term solutions to joint disorders, ranges from minor repair to total joint replacement. Implants of all kinds, including knee replacement implants, hip replacement implants, and others, are used in reconstructive joint replacements.

One kind of medical tool used to treat disorders of the spine is the spinal implant. The 33 vertebrae that make up the spinal column support the body when it is sitting, standing, or bending. The sacrum, coccyx, thoracic, lumbar, and cervical vertebrae are among the five parts of the vertebrae. For movement, each section has a spinal disc. In addition, spinal implants come in various sizes, shapes, and functions due to the complexity of the spine. PEEK and titanium alloys are the main components of spinal implants. In disc replacement type spinal implants, cobalt-chromium alloys are used. Around 1.4 million spinal procedures are carried out annually in the US, according to the North American Spine Society. Over 350,000 procedures were performed, with cervical fixation accounting for most of those.

Request Customizationto receive a tailored report.

Material Class Insights

The non-metal segment owns the highest market share and is expected to grow at a CAGR of 8.28% during the forecast period. Using the polyetheretherketone (PEEK) implant material systems from the magnum PI, surgeons can use alternatives instead of metal anchors. Among many other indications, the system can be seen in several surgical procedures involving shoulder and foot Achilles tendon replacements. The procedure is made simple, quick, and secure by an implant, cortical bone lock, knotless fixation, and a straightforward technique. An easy-to-use implanted handle is placed inside the implant.

Most elements in the periodic table are metals. Metallic biomaterials are primarily used in load-bearing systems, such as hip and knee prostheses, and to repair internal and external bone fractures. It is crucial to understand how the various metallic materials used in orthopedic surgery interact with host tissue in the human body and their physical and chemical characteristics.

Application Insights

The joint replacement segment is the highest contributor to the market and is expected to grow at a CAGR of 7.88% during the forecast period. The joint replacement procedure removes and replaces diseased or damaged joint components with fresh, synthetic ones. The pain and discomfort can be lessened, and the joint replaced. Hip and knee reconstructions are the most common. Other joints could stand in for the elbows, ankles, shoulders, fingers, etc. In addition, the rise in knee replacement surgeries, robotic-assisted surgeries, and the launch of products like the Persona Partial Knee System, ATTUNE Revision Knee System, and JOURNEY II XR Total Knee by major manufacturers have all contributed to the knee segment's growth during the forecast period.

The primary causes of orthopedic fracture fixation include an aging population, an increase in the use of new technologies, an increase in osteoporosis prevalence, and an increase in injuries. The decline in bone fractures caused by changes in lifestyle, such as inactivity, early burnout, and rising obesity rates worldwide, is fueling the market for orthopedic implants.

End-User Insights

The hospitals and clinics segment owns the highest market share and is expected to grow at a CAGR of 8.12% during the forecast period.

Speak to an Analystto discuss market opportunities.

Regional Insights

Americas is the most significant shareholder in the global orthopedic biomaterials market and is expected to grow at a CAGR of 7.92% during the forecast period. The Americas dominated the orthopedic biomaterials market in 2022 and is anticipated to hold this position throughout the evaluation period. This is explained by the high incidence of orthopedic diseases, new product introductions, and technological development in this area. The regional market is anticipated to grow due to the high demand for orthopedic biomaterial and the adequate supply of skilled workers. In addition, the market for orthopedic biomaterials in the Americas is expanding due to the region's aging population. According to the Administration for Community Living, the number of people 65 and older increased in the Americas over the past ten years, from 37.2 million in 2006 to 49.2 million in 2016. Therefore, factors such as a sizable patient pool with orthopedic conditions, a rapidly expanding market, and an increasing geriatric population are anticipated to spur the growth of the orthopedic biomaterials market in the Americas during the study period.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Orthopedic Biomaterials Market Trends

Europe is expected to grow at a CAGR of 7.35% during the forecast period. Europe, which held the second-largest share of the orthopedic biomaterials market in 2022, is anticipated to witness considerable growth throughout the forecast period due to an increase in patients and the accessibility of products in the area. Switzerland, Finland, Luxembourg, Germany, Austria, and Belgium were among the nations in the area with the most hip and knee replacements performed in 2017. The OECD averages for hip and knee replacements are 182 and 135 per 100,000 people. In most OECD nations since 2000, hip and knee replacement surgeries have rapidly increased. Between 2007 and 2017, the average number of hip and knee replacements increased by 30% and 40%, respectively. The local market's growth is anticipated to be boosted by the number of patients undergoing knee replacement.

Asia-Pacific is expected to experience the fastest growth over the forecast period. The United Nations projects that over the next 50 years, the proportion of people 65 and older will significantly increase throughout Asia. This age group's population in the area will increase by 31.4% from 207 million in 2000 to 857 million in 2050. In addition, many adults living in the area are anticipated to experience different cardiac and orthopedic conditions. Further, people spend more money on health due to the rising per capita disposable income of middle-class families, who comprise a significant portion of the population in Asia. This is one of the elements contributing to the regional global market's growth over the study.

The Middle East and Africa have seen a steady increase in the market for orthopedic biomaterials over the forecast period. The rising incidence of orthopedic disorders and funding from private and public entities are the main drivers of regional market expansion. According to a report by the International Trade Administration, the Saudi healthcare industry is the biggest in the Near East. The 2019 budget for Saudi Arabia's health and social affairs calls for an 8% increase to USD 46 billion from USD 42.4 billion in 2018. Additionally, expanding businesses and affiliates in the area that provide orthopedic biomaterial contributes to the market's expansion.

List of Key and Emerging Players in Orthopedic Biomaterials Market